These findings identify a novel molecular link between YAP1–NMU expression and pancreatic cancer metastasis and poor prognosis and suggest that targeting YAP1 and NMU could be a new treatment strategy for pancreatic cancer. Here, NMU is linked to familial pancreatic carcinoma.